What is Chardan Capital’s Forecast for IPSC FY2025 Earnings?
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Research analysts at Chardan Capital upped their FY2025 EPS estimates for shares of Century Therapeutics in a note issued to investors on Monday, May 19th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earnings of ($0.30) per share for the year, up from […]
Century Therapeutics, Inc. (NASDAQ:IPSC – Free Report) – Research analysts at Chardan Capital upped their FY2025 EPS estimates for shares of Century Therapeutics in a note issued to investors on Monday, May 19th. Chardan Capital analyst Y. Livshits now anticipates that the company will post earnings of ($0.30) per share for the year, up from […]
